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In an in vitro synthesizing system programmed with RNA from human liver a polypeptide with an 
estimated Nr of 80000 (80 kDa) it 1400 (mean f SD, n = 5) was synthesized. This polypeptide could be 
precipitated with antiserum to a narrow density cut of LDL (d = 1.030-1.055) or antiserum against the 
high-M, form of apoB (apoB 100 141). The synthesized protein is ~rnunolo~~~y related to a 75 kDa 
protein isolated from LDL. We suggest that the 80 kDa protein represents a primary translation product 
of apoB synthesized in human liver. 
Apolipoprotein B Human iiver RNA 
1, INTRODUCTION 
The dominant protein component of LDL is 
known as apolipoprotein B (apoB). In several in- 
vestigations apoB has been found to be a high+%& 
protein (250 kDa or 549 kDa) when analysed by 
SDS-PAGE [l-4] or by sedimentation 
equilibrium centrifugation [5,9]. However, pro- 
teins with considerably ower &values have also 
been reported to be associated with LDL [4,6-lo]. 
These proteins have been shown to be related to 
apoB by immunologic~ methods [&lo]. The 
reasons for these conflicting findings are not clear. 
The possibility that the proteins with lower i%- 
values are proteolytic products of the high-M, 
form of apoB has been discussed [3,4,11-131. On 
Abbreviations: DU, density units; LDL, low density 
lipoproteins (d = 1.019-l .063); LDL (d = 1.030-I .055), 
a narrow density cut of LDL; Lp-B, lipoprotein B; apo, 
apolipoprotein; apo LDL (d = 1.030-l .055), the protein 
component of a narrow density cut of LDL; SD, stan- 
dard deviation; SDS-PAGE, sodium dodecyl 
sulphate-~lyacryla~de gel electrophoresis; PMSF, 
phenylmethylsulfonylfluoride 
In vitro translation Low density lipoprotein 
the other hand, it has also been suggested that the 
high-M, form of apoB represents a polymer of the 
low-&& polypeptide(s) [8,14]. One reason for such 
polymerization may be the different methods used 
for delipidization of LDL and for solubili~ation of
apoB [18]. 
To further investigate he structure of apoB, we 
have studied the formation in an in vitro protein 
synthesizing system programmed with human liver 
RNA of a polypeptide that reacted with antiserum 
against a narrow density cut of LDL (d = 
1.030-1.055) and ~tiserum against he high-&& 
form of apoB. 
2. MATERIALS AND METHODS 
Sepharose CL 4B, CNBr-activated Sepharose 
4B, and the Electrophoretic Calibration Kit were 
from Pharmacia (Uppsala). The reticulocyte lysate 
translation kit and EN3HANCE were from New 
England Nuclear (ffoston MA). 13’S]Methionine 
(1500 Wmmol) was from Amersham 
(Buckinghamshire). 
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2.2. Isolation of a high-M,protein from a narrow 
density cut of LDL 
A narrow density cut of LDL (d = 1.030-l .055) 
was isolated in the presence of 0.1% EDTA, 1 mM 
PMSF, 0.1% thiomerasal, 50000 III/I penicillin 
and 50 mg/l streptomycin with stepwise ultracen- 
trifugation as in [lo]. The delipidization of LDL 
and solubilization of the remaining protein were 
carried out as in [lo]. The solubili~d apoLDL was 
chromatography on Sephadex G-100, DEAE- 
cellulose and Sepharose CL 6B as in [lo], with the 
following exceptions: 
(i) All buffer solutions contained 0.1% NaNr and 
1 mM PMSF; 
(ii) chromatography was carried out at 4°C or 
9°C (when buffers containing 8 M urea were 
used). 
The majority of the material recovered from the 
column (-70%) was eluted with the void volume. 
This fraction was rechromatographed 3 times on a 
Sepharose CL 4B column (93 x 2.5 cm) in 0.01 M 
Tris-HCl (PH 8.0) with 8 M urea, 5% 
2-mercaptoethanol, 0.1% NaN3 and 1 mM PMSF. 
The purified fraction appeared as one band on 
electrophoresis in 3 or 7.5% polyacrylamide gels 
containing SDS. The estimated M, and the amino 
acid composition agreed closely with those 
reported for the liver-derived high% protein of 
apoLDL, referred to as apoB 100 [4]. The isolated 
protein will, therefore, be referred to as apoB 100. 
2.3. rsolat~on of a 75 kDa protein from a narrow 
density cut of LDL 
Isolation of the 75 kDa protein from LDL (d = 
1.030-l ,055) was carried out as in [lo] with the 
following exceptions: 
(i) The LDL was isolated in the presence of 0.1% 
EDTA, 1 mM PMSF, 0.1% thiomerasal, 
50000 IUll pe~cillin and 50 mg/l strepto- 
mycin; 
(ii) All buffer solutions used contained 0.1% 
NaN3 and 1 mM PMSF; 
(iii) Chromatography was carried out at 4°C or 
9°C (when buffers containing 8 M urea were 
used). The protein will be referred to as 
apoB75 kDa. 
2.4. Immunological methods 
Antisera were raised as in [lo]. Antiserum to 
Lp-B was prepared by injecting LDL (d = 
64 
1.030-l .055). Four different immunoglobulin 
preparations were used for the immunoprecipita- 
tion of in vitro synthesized apoB: 
(i) The total immunoglobulin fraction prepared 
by ammonium sulphate precipitation 1181 of 
serum from non-immunized rabbits; 
(ii) The total immunoglobulin fraction prepared 
by ammonium sulphate precipitation of serum 
from rabbits immunized with LDL (d = 
1.030-l .OSS); 
(iii) The specific immunoglobulin fraction from 
rabbits immunized with LDL (d = 
1.030-l .055); 
(iv) The specific immunoglobulin fraction from 
rabbits immunized with apoB 100. 
The LDL- and apoB RIO-specific im- 
munoglobulin fractions (iii,iv) were obtained by 
separate chromatographies of the corresponding 
antisera on a column of CNBr-activated Sepharose 
4B coupled with LDL (d = 1,030-l .055). The frac- 
tion of each of the antisera retained by the column 
was eluted with 3 M NaSCN and desalted on a 
Sephadex G-25 column equilibrated with 0.1 M 
NaHCOr (pH 8.3) with 0.5 M NaCl. 
All immunoglobulin fractions (i-iv) were coupl- 
ed to CNBr-activated Sepharose 4B. They will be 
referred to as: 
(i) non-immune-IG-Sepharose; 
(ii) anti-Lp-B-Sepharose; 
(iii) anti-Lp-B (specific IG)-Sepharose; 
(iv) anti-apoB 100 (specific IG)-Sepharose. 
Coupli.ng of proteins to CNBr-activated 
Sepharose 4B was carried out as r~ommended by 
the manufacturer. 
2.5, Synthesis of protein in a ceil-free system 
RNA was prepared [17] from human liver biop- 
sies (l-4 g wet wt) obtained during cholecystec- 
tomy. The incubation mixture contained 50~1 
reticulocyte lysate, 27.5 ~1 translation cocktail, 
10~1 [35S]methionine (9.7 mCi/ml), 10~1 1 M 
potassium acetate, 2.5 ~1 32.5 mM magnesium 
acetate, 15 /rl distilled water and 10 $1 human liver 
RNA (100 DU/ml). The reaction mixture was in- 
cubated for 60 mm at 37°C. 
Immunoprecipitation of polypeptides reacting 
with antibodies against LDL (d = 1.030-l .055) or 
apoB 100 was done as in [ 181 using the Sepharose 
coupled immunoglobulin fractions described 
above (i.e., non-immune-Ig-Sepharose, anti-lp- 
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B-Sepharose, anti-Lp-B (specific IG)-Sepharose 
and anti-apoB 100 (specific IG)-Sepharose). 
Precipitated proteins were analysed with 
SDS-PAGE (7.5%) [15], using proteins of known 
M-values as standards. Autoradiography was per- 
formed by fluorography [19] in the presence of 
EN311ANCE. 
3. RESULTS 
The rabbit reticulocyte lysate system, pro- 
grammed with unfractionated RNA from human 
liver, synthesized a polypeptide that was specifical- 
ly bound to the antibodies against LDL (d = 
1.030-1.055) (fig. 1) as well as to the antibodies 
against apoB 100 (fig.2). About 0.4% of the total 
radioactivity incorporated into protein was 
recovered in this polypeptide fraction. The M, of 
Fig.]. SDS-PAGE (7.5%) [IS] of proteins synthesized 
in the in vitro protein-synthesizing system programmed 
with human liver RNA. The dried gels were 
fluorographed for 12 h: (1) total translation mixture; (2) 
proteins bound to ~ti-Lp-B-~pharose; (3) proteins 
bound to non-immune IG-Sepharose; (4) proteins 
bound to anti-Lp-B (specific IG)-Sepharose. Dotted 
lines indicate the start of the separating gel (a)-(d) 
Migration of M, standards: (a) 94 kDa; (b) 67 kDa; (c) 
Since the Mrvalue of the synthesized polypep- 
tide is very similar to that of the 75 kDa protein 
{apoB7S kDa ) isolated from LDL by us [lo], we in- 
vestigated the relationship between the two 
polypeptides in an experiment where the protein- 
synthesizing mixture was supplemented with 
100 pg non-radioactive apoB” kDa before adding 
anti-Lp-B-Sepharose. This resulted in a signifi- 
cant reduction of the amount of radioactive pro- 
tein specifically bound to anti-Lp-B-Sepharose 
(fig.3). Thus, it appears that apoB75 kDa and the 
protein of MI 80000 compete for the same antigen- 
binding sites. 
60 kDa; (d) 43 kDa. Under the conditions used we have not been able 
Fig.2. SDS-PAGE (7.5%) [15] of proteins synthesized 
in the in vitro protein-synthes~g system pro~~med 
with human liver RNA. The dried gels were 
fluorographed for 12 h (1) and 76 h (2): (1) total 
translation mixture; (2) proteins bound to anti-apoB 100 
(specific IG)-Sepharose; (3) proteins bound to non- 
immune IG-Sepharose. Dotted lines indicate the start of 
the separating gel. (a)-(d) indicate the migration of && 
standards (cf. fig. 1). 
the synthesized polypeptide was estimated to be 
80000 j, 1400 (mean f SD, n = 5) as judged from 
its migration in the 7.5% SDS-slab gels in relation 
to proteins with known M-values (cf. fig.l-3). 
65 
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Based on these data, we suggest hat a 80 kDa 
polypeptide belonging to apoB is synthesized in the 
human liver. This polypeptide appears to be pre- 
sent as a monomer within LDL. It is also possible 
that it occurs as one subunit of a high-M, protein 
of LDL. The nature of this high-M protein and its 
relationship to the 80 kDa protein synthesized in 
human liver is under investigation in our 
laboratory. 
d- 
Fig.3. SDS-PAGE (7.5%) [IS] of proteins synthesized 
in the in vitro protein-synthesizing system with human 
liver RNA. The dried gels were fluorographed 12 h: (1) 
proteins bound to anti-Lp-B-Sepharose; (2) proteins 
bound to anti-Lp-B-Sepharose when the in vitro 
protein-synthesizing has been supplemented with 100 ,ug 
non-radioactive apoB75 kDa before adding the anti-lp- 
B-Sepharose. Arrows indicate the start of the separating 
gel. (a)-(d) Migration of M, standards (cf. fig.1). 
to detect he synthesis of a protein with an M cor- 
responding to apoB 100. Obviously, this does not 
exclude the possibility of its presence. 
4. DISCUSSION 
The structure of the protein moiety of LDL 
(apoB) is still unsettled. Several authors have 
reported that apoB consists of a high-M protein 
(250 kDa or 549 kDa) [l-5]. The possibility that 
this high-M, protein is a polymer of polypeptides 
with a considerably lower M, has been suggested by 
other authors [6-8,141. This hypothesis is com- 
patible with the results presented here showing that 
an in vitro protein-synthesizing system programm- 
ed with RNA from human liver, synthesized a 
80 kDa polypeptide that could be precipitated with 
antibodies against LDL (d = 1.030-l .055) and 
with antibodies against apoB 100 [4]. Since the 
synthesized 80 kDa protein is immunologically 
related to a protein of an estimated 75 kDa present 
in LDL, our data can also lend support to the find- 
ing by several authors that a protein component of 
70-80 kDa is present within LDL [7-lo]. 
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